Assura Plc (ARSSF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Assura Plc (ARSSF) trades at $0.68 with AI Score 51/100 (Grade B). Assura plc is a UK-based real estate investment trust (REIT) focused on primary care properties. Market cap: $2.20B, Sector: Real estate.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for ARSSF: ARSSF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ARSSF against Real Estate peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
ARSSF: 3/7 perspectives are bullish. Dominant signal: Ken Griffin bearish.
How is this calculated? →Assura Plc (ARSSF) Real Estate Portfolio & Strategy
Assura plc, a FTSE 250 constituent, is a UK REIT specializing in primary care property. The company invests in and develops healthcare facilities, collaborating with GPs and the NHS to provide community health service spaces, with a property portfolio valued at £2,259 million as of September 2020.
What Is the Investment Thesis for ARSSF?
Assura plc presents a compelling investment case due to its focus on the growing primary care property market in the UK. The company's strong profit margin of 90.3% and gross margin of 90.9% highlight its efficient operations and ability to generate revenue from its property portfolio. With a dividend yield of 3.54%, Assura offers an attractive income stream for investors. The company's beta of 0.60 suggests lower volatility compared to the overall market. Growth catalysts include the increasing demand for primary care services and the ongoing need for modern, well-equipped healthcare facilities. However, potential risks include changes in government healthcare policy and fluctuations in property values.
Based on FMP financials and quantitative analysis
ARSSF Key Highlights
- Property portfolio valued at £2,259 million as of September 30, 2020, demonstrating a substantial asset base.
- Profit margin of 90.3% indicates strong operational efficiency and profitability.
- Gross margin of 90.9% reflects effective cost management in property operations.
- Dividend yield of 3.54% provides an attractive income stream for investors.
- Beta of 0.60 suggests lower volatility compared to the broader market, offering stability.
Who Are ARSSF's Competitors?
ARSSF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BOWFF Boardwalk Real Estate Investment Trust | $45.94 | +0.55% | $2.19B | 50 |
| BUNNF BWP Trust | $2.88 | -7.10% | $2.05B | 49 |
| CNPPF China Overseas Property Holdings Limited | $0.43 | +0.00% | $1.41B | 43 |
| GPEAF Great Portland Estates Plc | $4.01 | +0.00% | $1.62B | 45 |
| GRDDY Grand City Properties S.A. | $12.80 | -3.25% | $2.25B | 53 |
| LTC LTC Properties, Inc. | $45.07 | -1.43% | 66 | |
| STRW Strawberry Fields REIT LLC | $13.68 | -0.65% | $183.68M | 60 |
| WELL Welltower Inc. | $232.48 | -1.52% | $164.11B | 58 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ARSSF's Key Strengths?
- Strong focus on the growing primary care property market.
- Long-term leases with healthcare providers provide stable income.
- High occupancy rates demonstrate the value of its properties.
- Constituent of the FTSE 250 and EPRA indices.
What Are ARSSF's Weaknesses?
- Reliance on the UK healthcare system.
- Potential impact from changes in government healthcare policy.
- Vulnerability to fluctuations in property values.
- Limited geographic diversification.
What Could Drive ARSSF Stock Higher?
- Increasing demand for primary care services in the UK.
- Government initiatives to improve primary care infrastructure.
- Strategic partnerships with healthcare providers.
- Potential acquisitions of existing healthcare properties.
- Investment in technology and innovation to enhance property value.
What Are the Key Risks for ARSSF?
- Financial-distress signal — its Altman Z-Score of 0.91 sits in the distress zone (elevated bankruptcy risk).
- Changes in government healthcare policy.
- Fluctuations in property values.
- Competition from other REITs and property developers.
- Economic downturn impacting property values.
- Rising interest rates increasing borrowing costs.
What Are the Growth Opportunities for ARSSF?
- Expansion of Primary Care Facilities: The increasing demand for primary care services in the UK presents a significant growth opportunity for Assura. As the population ages and healthcare needs evolve, there is a growing need for modern, well-equipped primary care facilities. Assura can capitalize on this trend by developing new properties and expanding its existing portfolio, potentially increasing its market share and revenue. Timeline: Ongoing.
- Strategic Partnerships with Healthcare Providers: Collaborating with GPs, health professionals, and the NHS can drive growth for Assura. By working closely with these stakeholders, Assura can develop properties that meet their specific needs and requirements, ensuring high occupancy rates and long-term leases. These partnerships can also provide Assura with valuable insights into the evolving healthcare landscape, allowing it to stay ahead of the curve and adapt its properties accordingly. Timeline: Ongoing.
- Investment in Technology and Innovation: Integrating technology into its properties can enhance the patient experience and improve operational efficiency. Assura can invest in telehealth infrastructure, remote monitoring systems, and other innovative technologies to create smart healthcare facilities. This can attract healthcare providers and patients alike, driving demand for Assura's properties and increasing its revenue. Timeline: Ongoing.
- Acquisition of Existing Healthcare Properties: Acquiring existing healthcare properties can provide Assura with a quick and efficient way to expand its portfolio. By targeting properties that are well-located and have strong occupancy rates, Assura can generate immediate revenue and increase its asset base. This strategy can also help Assura diversify its portfolio and reduce its reliance on new developments. Timeline: Ongoing.
- Focus on Sustainability and Environmental Responsibility: Implementing sustainable building practices and reducing its environmental footprint can enhance Assura's reputation and attract socially responsible investors. By incorporating energy-efficient technologies, using sustainable materials, and reducing waste, Assura can create environmentally friendly healthcare facilities. This can also help Assura reduce its operating costs and improve its long-term financial performance. Timeline: Ongoing.
What Opportunities Does ARSSF Have?
- Expansion of primary care facilities to meet increasing demand.
- Strategic partnerships with healthcare providers.
- Investment in technology and innovation to enhance property value.
- Acquisition of existing healthcare properties to expand portfolio.
What Threats Does ARSSF Face?
- Competition from other REITs and property developers.
- Economic downturn impacting property values.
- Changes in healthcare regulations.
- Rising interest rates increasing borrowing costs.
What Are ARSSF's Competitive Advantages?
- Long-term leases with healthcare providers provide stable income.
- Focus on primary care properties creates a niche market position.
- Strong relationships with GPs and the NHS provide a competitive advantage.
- High occupancy rates demonstrate the value of its properties.
What Does ARSSF Do?
Assura plc is a UK-based real estate investment trust (REIT) focused on investing in, developing, and managing primary care properties. Founded with the aim of providing modern and efficient healthcare facilities, Assura works closely with general practitioners (GPs), health professionals, and the National Health Service (NHS) to create spaces that meet the evolving needs of community healthcare. The company's portfolio includes a range of properties, from purpose-built medical centers to refurbished healthcare facilities, all designed to support the delivery of high-quality primary care services. Assura's strategy involves long-term investment in its properties, ensuring they are well-maintained and adaptable to changing healthcare needs. The company also actively develops new primary care facilities, working in partnership with healthcare providers to create modern, fit-for-purpose buildings. Headquartered in Warrington, UK, Assura is a constituent of the FTSE 250 index and the EPRA indices, reflecting its significant position in the UK REIT market. As of September 30, 2020, Assura's property portfolio was valued at £2,259 million, demonstrating its substantial asset base and commitment to the primary care sector.
What Products and Services Does ARSSF Offer?
- Invests in primary care properties in the UK.
- Develops new healthcare facilities in partnership with GPs and the NHS.
- Manages and maintains its existing property portfolio.
- Works with healthcare providers to create modern and efficient spaces.
- Provides long-term investment in primary care infrastructure.
- Ensures properties are adaptable to changing healthcare needs.
How Does ARSSF Make Money?
- Generates revenue through rental income from its property portfolio.
- Develops new properties and leases them to healthcare providers.
- Increases property value through active management and development.
- Distributes profits to shareholders through dividends.
What Industry Does ARSSF Operate In?
Assura plc operates within the REIT - Healthcare Facilities industry, which is experiencing growth due to the increasing demand for healthcare services and the need for modern, well-equipped facilities. The UK primary care property market is driven by factors such as an aging population, rising healthcare expenditure, and government initiatives to improve primary care infrastructure. Assura competes with other REITs and property developers in the healthcare sector, including companies like BOWFF (Boardwalk Real Estate Investment Trust), BUNNF (Bunnings Warehouse Property Trust), CNPPF (Canadian Apartment Properties REIT), GPEAF (Great Portland Estates PLC), and GRDDY (Great Divide Resources, Corp.).
Who Are ARSSF's Key Customers?
- General Practitioners (GPs)
- Health Professionals
- National Health Service (NHS)
- Patients
FY2026 estForward Outlook
Wall Street analysts project Assura Plc revenue of about $267.8M for fiscal 2026, with EPS near $0.05.
Quarterly Financial Performance: Assura Plc
Revenue for Assura Plc came in at $99.2M during Q1 2025, a 17.3% improvement versus the preceding quarter. The company recorded net income of $88.9M, with diluted EPS of $0.03. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this mid-cap Real Estate company.
ARSSF Valuation & Market Position
With a $2.20B market cap, Assura Plc sits in the mid-cap segment of the market. Relative to its peer group, ARSSF's quantitative score of 51/100 is roughly in line with the peer average of 48/100.
ROE 11%Key Financial Metrics
Return on equity for Assura Plc stands at 10.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 5.1%, showing how much profit it generates from its asset base. ARSSF trades at a trailing price-to-earnings ratio of 9.03, below the Real Estate sector average of ~20x. Its free cash flow yield is 5.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.73 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 11.1%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 5/9Financial Health
Assura Plc's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.91 places it in the distress zone, a signal of elevated financial risk.
Company Profile
Assura Plc operates in the REIT - Healthcare Facilities industry within the Real Estate sector. It is headquartered in Warrington, GB. The company is led by CEO Jonathan Stewart Murphy. ARSSF has traded publicly since 2021.
ARSSF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Strong focus on the growing primary care property market.
- Long-term leases with healthcare providers provide stable income.
- High occupancy rates demonstrate the value of its properties.
- Constituent of the FTSE 250 and EPRA indices.
Bear Case
- Reliance on the UK healthcare system.
- Potential impact from changes in government healthcare policy.
- Vulnerability to fluctuations in property values.
- Limited geographic diversification.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2025 | $99M | $89M | $0.03 |
| Q3 2024 | $85M | $77M | $0.03 |
| Q1 2024 | $81M | $3.00B | -$0.0047 |
Based on FMP financials and quantitative analysis
ARSSF Latest News
No recent news available for ARSSF.
ARSSF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ARSSF.
Price Targets
Wall Street price target analysis for ARSSF.
ARSSF MoonshotScore
What does this score mean?
The MoonshotScore rates ARSSF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Jonathan Stewart Murphy
CEO
Jonathan Stewart Murphy serves as the CEO of Assura plc, bringing extensive experience in real estate and healthcare infrastructure. His background includes leadership roles in property development and investment firms, with a focus on creating sustainable and community-focused healthcare spaces. Murphy's expertise lies in strategic planning, portfolio management, and stakeholder engagement. He is committed to driving Assura's growth and delivering value to its shareholders.
Track Record: Under Jonathan Stewart Murphy's leadership, Assura plc has continued to expand its portfolio of primary care properties and strengthen its relationships with healthcare providers. He has overseen the development of new, state-of-the-art facilities and the implementation of innovative technologies to improve patient care. Murphy's strategic decisions have contributed to Assura's strong financial performance and its position as a leading REIT in the healthcare sector.
ARSSF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Assura plc (ARSSF) may have limited regulatory oversight and disclosure requirements compared to companies listed on major exchanges like the NYSE or NASDAQ. Companies in this tier often do not meet the minimum financial standards or reporting requirements necessary for listing on higher-tier exchanges. Investors should be aware that stocks in the OTC Other tier can be more speculative and carry higher risks due to the lack of stringent listing standards.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited regulatory oversight and disclosure requirements.
- Potential for lower trading volume and liquidity.
- Increased price volatility due to thin trading.
- Higher risk of fraud or manipulation compared to listed exchanges.
- Difficulty in obtaining reliable information about the company.
- Verify the company's registration and regulatory filings.
- Review the company's financial statements, if available.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Monitor trading volume and price movements.
- Consult with a financial advisor before investing.
- Constituent of the FTSE 250 index, indicating a certain level of market capitalization and investor interest.
- Focus on primary care properties, a sector with growing demand.
- Partnerships with GPs and the NHS, suggesting credibility and established relationships.
- Property portfolio valued at £2,259 million as of September 2020, demonstrating a substantial asset base.
- Dividend yield of 3.54%, providing an income stream for investors.
What Investors Ask About Assura Plc (ARSSF) — Real Estate
What does Assura Plc do?
Assura plc is a UK-based real estate investment trust (REIT) specializing in primary care properties. The company invests in, develops, and manages healthcare facilities, working closely with GPs, health professionals, and the NHS to create modern and efficient spaces for community health services. Assura's business model focuses on long-term investment in its properties, ensuring they are well-maintained and adaptable to changing healthcare needs. The company generates revenue through rental income from its property portfolio and distributes profits to shareholders through dividends.
What are the main risks for ARSSF?
The main risks for Assura plc include potential changes in government healthcare policy, which could impact the demand for primary care properties and the company's revenue. Fluctuations in property values could also affect Assura's asset base and financial performance. Competition from other REITs and property developers in the healthcare sector poses a threat to Assura's market share. Additionally, an economic downturn could negatively impact property values and increase vacancy rates. Rising interest rates could increase borrowing costs and reduce Assura's profitability.
What are the key factors to evaluate for ARSSF?
Assura Plc (ARSSF) holds an AI score of 51/100 (moderate). P/E: 9.0x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does ARSSF data refresh on this page?
ARSSF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ARSSF's recent stock price performance?
Assura Plc (ARSSF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong focus on the growing primary care property market. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ARSSF overvalued or undervalued right now?
Assura Plc (ARSSF) trades at 9.0x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying ARSSF?
Before investing in Assura Plc (ARSSF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding ARSSF to a portfolio?
Key strength of Assura Plc (ARSSF): Strong focus on the growing primary care property market. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for ARSSF, limiting the depth of some sections.
- Financial data is based on information available as of 2020-09-30.